Hecht FM - Search Results

1

Use of laboratory tests and clinical symptoms for identification of primary HIV infection.

Hecht FM, Busch MP, Rawal B, Webb M, Rosenberg E, Swanson M, Chesney M, Anderson J, Levy J, Kahn JO. Hecht FM, et al. AIDS. 2002 May 24;16(8):1119-29. doi: 10.1097/00002030-200205240-00005. AIDS. 2002. PMID: 12004270 Clinical Trial.

2

New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes.

Janssen RS, Satten GA, Stramer SL, Rawal BD, O'Brien TR, Weiblen BJ, Hecht FM, Jack N, Cleghorn FR, Kahn JO, Chesney MA, Busch MP. Janssen RS, et al. Among authors: hecht fm. JAMA. 1998 Jul 1;280(1):42-8. doi: 10.1001/jama.280.1.42. JAMA. 1998. PMID: 9660362

3

Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors.

Hecht FM, Grant RM, Petropoulos CJ, Dillon B, Chesney MA, Tian H, Hellmann NS, Bandrapalli NI, Digilio L, Branson B, Kahn JO. Hecht FM, et al. N Engl J Med. 1998 Jul 30;339(5):307-11. doi: 10.1056/NEJM199807303390504. N Engl J Med. 1998. PMID: 9682043 Free article. No abstract available.

4

HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: response to both initial and salvage therapy.

Deeks SG, Hecht FM, Swanson M, Elbeik T, Loftus R, Cohen PT, Grant RM. Deeks SG, et al. Among authors: hecht fm. AIDS. 1999 Apr 16;13(6):F35-43. doi: 10.1097/00002030-199904160-00001. AIDS. 1999. PMID: 10397555

5

Quantitative and cost comparison of ultrasensitive human immunodeficiency virus type 1 RNA viral load assays: Bayer bDNA quantiplex versions 3.0 and 2.0 and Roche PCR Amplicor monitor version 1.5.

Elbeik T, Charlebois E, Nassos P, Kahn J, Hecht FM, Yajko D, Ng V, Hadley K. Elbeik T, et al. Among authors: hecht fm. J Clin Microbiol. 2000 Mar;38(3):1113-20. doi: 10.1128/JCM.38.3.1113-1120.2000. J Clin Microbiol. 2000. PMID: 10699005 Free PMC article.

6

Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population.

Bangsberg DR, Hecht FM, Charlebois ED, Zolopa AR, Holodniy M, Sheiner L, Bamberger JD, Chesney MA, Moss A. Bangsberg DR, et al. Among authors: hecht fm. AIDS. 2000 Mar 10;14(4):357-66. doi: 10.1097/00002030-200003100-00008. AIDS. 2000. PMID: 10770537

7

Adherence: a necessity for successful HIV combination therapy.

Chesney MA, Ickovics J, Hecht FM, Sikipa G, Rabkin J. Chesney MA, et al. Among authors: hecht fm. AIDS. 1999;13 Suppl A:S271-8. AIDS. 1999. PMID: 10885784 Review.

8

Does HIV reporting by name deter testing? MESH Study Group.

Hecht FM, Chesney MA, Lehman JS, Osmond D, Vranizan K, Colman S, Keane D, Reingold A, Bindman AB. Hecht FM, et al. AIDS. 2000 Aug 18;14(12):1801-8. doi: 10.1097/00002030-200008180-00016. AIDS. 2000. PMID: 10985318

9

Longitudinal analysis of T-cell receptor gene use by CD8(+) T cells in early human immunodeficiency virus infection in patients receiving highly active antiretroviral therapy.

Schito AM, Vittinghoff E, Hecht FM, Elkins MK, Kahn JO, Levy JA, Oksenberg JR. Schito AM, et al. Among authors: hecht fm. Blood. 2001 Jan 1;97(1):214-20. doi: 10.1182/blood.v97.1.214. Blood. 2001. PMID: 11133763 Free article.

10

Reduction in CD8+ cell noncytotoxic anti-HIV activity in individuals receiving highly active antiretroviral therapy during primary infection.

Stranford SA, Ong JC, Martinez-Marino B, Busch M, Hecht FM, Kahn J, Levy JA. Stranford SA, et al. Among authors: hecht fm. Proc Natl Acad Sci U S A. 2001 Jan 16;98(2):597-602. doi: 10.1073/pnas.98.2.597. Epub 2001 Jan 2. Proc Natl Acad Sci U S A. 2001. PMID: 11136234 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

618 results

Search Page

Filters